Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells MM Ho, AV Ng, S Lam, JY Hung Cancer research 67 (10), 4827-4833, 2007 | 1308 | 2007 |
Bladder cancer PE Clark, N Agarwal, MC Biagioli, MA Eisenberger, RE Greenberg, ... Journal of the National Comprehensive Cancer Network 11 (4), 446-475, 2013 | 428 | 2013 |
Prostate cancer, version 2.2014 JL Mohler, PW Kantoff, AJ Armstrong, RR Bahnson, M Cohen, ... Journal of the National Comprehensive Cancer Network 12 (5), 686-718, 2014 | 401 | 2014 |
NCCN task force report: management of neuropathy in cancer MD Stubblefield, HJ Burstein, AW Burton, CM Custodio, GE Deng, M Ho, ... Journal of the National Comprehensive Cancer Network 7 (Suppl_5), S-1-S-26, 2009 | 322 | 2009 |
Prostate cancer, version 3.2012 featured updates to the NCCN guidelines JL Mohler, AJ Armstrong, RR Bahnson, B Boston, JE Busby, AV D’Amico, ... Journal of the National Comprehensive Cancer Network 10 (9), 1081-1087, 2012 | 289 | 2012 |
Presentation and management of docetaxel-related adverse effects in patients with breast cancer MY Ho, JR Mackey Cancer management and research, 253-259, 2014 | 223 | 2014 |
Penile cancer PE Clark, PE Spiess, N Agarwal, MC Biagioli, MA Eisenberger, ... Journal of the National Comprehensive Cancer Network 11 (5), 594-615, 2013 | 207 | 2013 |
Central nervous system cancers LB Nabors, M Ammirati, PJ Bierman, H Brem, N Butowski, ... Journal of the National Comprehensive Cancer Network 11 (9), 1114-1151, 2013 | 184 | 2013 |
Melanoma, version 2.2013: featured updates to the NCCN guidelines DG Coit, R Andtbacka, CJ Anker, CK Bichakjian, WE Carson, A Daud, ... Journal of the National Comprehensive Cancer Network 11 (4), 395-407, 2013 | 177 | 2013 |
NCCN task force: clinical utility of PET in a variety of tumor types DA Podoloff, DW Ball, E Ben-Josef, AB Benson, SJ Cohen, RE Coleman, ... Journal of the National Comprehensive Cancer Network 7 (Suppl_2), S-1-S-23, 2009 | 140 | 2009 |
MDR1 and BCRP1 expression in leukemic progenitors correlates with chemotherapy response in acute myeloid leukemia MM Ho, DE Hogge, V Ling Experimental hematology 36 (4), 433-442, 2008 | 135 | 2008 |
Prostate cancer, version 1.2014 JL Mohler, PW Kantoff, AJ Armstrong, RR Bahnson, M Cohen, ... Journal of the National Comprehensive Cancer Network 11 (12), 1471-1479, 2013 | 121 | 2013 |
Prostate cancer early detection, version 1.2014 PR Carroll, JK Parsons, G Andriole, RR Bahnson, DA Barocas, ... Journal of the National Comprehensive Cancer Network 12 (9), 1211-1219, 2014 | 118 | 2014 |
Central nervous system cancers, version 2.2014 LB Nabors, J Portnow, M Ammirati, H Brem, P Brown, N Butowski, ... Journal of the National Comprehensive Cancer Network 12 (11), 1517-1523, 2014 | 93 | 2014 |
Myeloid growth factors J Crawford, J Armitage, L Balducci, PS Becker, DW Blayney, SR Cataland, ... Journal of the National Comprehensive Cancer Network 11 (10), 1266-1290, 2013 | 88 | 2013 |
Melanoma, Version 4.2014 DG Coit, JA Thompson, R Andtbacka, CJ Anker, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 12 (5), 621-629, 2014 | 82 | 2014 |
Dermatofibrosarcoma protuberans, version 1.2014 CK Bichakjian, T Olencki, M Alam, JS Andersen, D Berg, GM Bowen, ... Journal of the National Comprehensive Cancer Network 12 (6), 863-868, 2014 | 61 | 2014 |
Gastrointestinal stromal tumors: disease and treatment update MY Ho, CD Blanke Gastroenterology 140 (5), 1372-1376. e2, 2011 | 56 | 2011 |
Merkel cell carcinoma, version 1.2014 CK Bichakjian, T Olencki, M Alam, JS Andersen, D Berg, GM Bowen, ... Journal of the National Comprehensive Cancer Network 12 (3), 410-424, 2014 | 52 | 2014 |
A combination of the effects of rare genotypes at the XK and KEL blood group loci results in absence of Kell system antigens from the red blood cells GL Daniels, F Weinauer, C Stone, M Ho, CA Green, H Jahn-Jochem, ... | 36 | 1996 |